This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Oct 7;390(10103):1628-1630.

doi: 10.1016/S0140-6736(17)32101-3. Epub 2017 Aug 3.

Insulin signalling: new target for Parkinson's treatments?

Werner Poewe¹, Klaus Seppi²

Affiliations

Affiliations

¹ Department of Neurology, Medical University Innsbruck, Anichstrasse 35, AT-6020 Innsbruck, Austria. Electronic address: werner.poewe@i-med.ac.at.
² Department of Neurology, Medical University Innsbruck, Anichstrasse 35, AT-6020 Innsbruck, Austria.

PMID: 28781109
DOI: 10.1016/S0140-6736(17)32101-3

Comment

Insulin signalling: new target for Parkinson's treatments?

Werner Poewe et al. Lancet. 2017.

. 2017 Oct 7;390(10103):1628-1630.

doi: 10.1016/S0140-6736(17)32101-3. Epub 2017 Aug 3.

Authors

Werner Poewe¹, Klaus Seppi²

Affiliations

¹ Department of Neurology, Medical University Innsbruck, Anichstrasse 35, AT-6020 Innsbruck, Austria. Electronic address: werner.poewe@i-med.ac.at.
² Department of Neurology, Medical University Innsbruck, Anichstrasse 35, AT-6020 Innsbruck, Austria.

PMID: 28781109
DOI: 10.1016/S0140-6736(17)32101-3

No abstract available

PubMed Disclaimer

Comment on

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T. Athauda D, et al. Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3. Lancet. 2017. PMID: 28781108 Free PMC article. Clinical Trial.

Similar articles

Insulin resistance and Parkinson's disease: A new target for disease modification?
Athauda D, Foltynie T. Athauda D, et al. Prog Neurobiol. 2016 Oct-Nov;145-146:98-120. doi: 10.1016/j.pneurobio.2016.10.001. Epub 2016 Oct 3. Prog Neurobiol. 2016. PMID: 27713036 Review.
Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Aviles-Olmos I, Limousin P, Lees A, Foltynie T. Aviles-Olmos I, et al. Brain. 2013 Feb;136(Pt 2):374-84. doi: 10.1093/brain/aws009. Epub 2012 Feb 17. Brain. 2013. PMID: 22344583 Review.
Treatment of Parkinson's disease : what's on the horizon?
Wu SS, Frucht SJ. Wu SS, et al. CNS Drugs. 2005;19(9):723-43. doi: 10.2165/00023210-200519090-00001. CNS Drugs. 2005. PMID: 16142989 Review.
Dementia is associated with insulin resistance in patients with Parkinson's disease.
Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, Mungari P, Fonte G, Consoli D, Consoli A, Fava A. Bosco D, et al. J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008. Epub 2012 Jan 21. J Neurol Sci. 2012. PMID: 22265943
Toward neuroprotective treatments of Parkinson's disease.
Kim KS. Kim KS. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3795-3797. doi: 10.1073/pnas.1703362114. Epub 2017 Mar 30. Proc Natl Acad Sci U S A. 2017. PMID: 28360200 Free PMC article. No abstract available.

See all similar articles

Cited by

Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
Azimullah S, Jayaraj RL, Meeran MFN, Jalal FY, Adem A, Ojha S, Beiram R. Azimullah S, et al. Molecules. 2023 Jan 10;28(2):685. doi: 10.3390/molecules28020685. Molecules. 2023. PMID: 36677744 Free PMC article.
Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.
Nedelcovych MT, Gadiano AJ, Wu Y, Manning AA, Thomas AG, Khuder SS, Yoo SW, Xu J, McArthur JC, Haughey NJ, Volsky DJ, Rais R, Slusher BS. Nedelcovych MT, et al. ACS Chem Neurosci. 2018 Apr 18;9(4):809-816. doi: 10.1021/acschemneuro.7b00434. Epub 2018 Jan 4. ACS Chem Neurosci. 2018. PMID: 29257872 Free PMC article.
Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases.
Shen J, Wang X, Wang M, Zhang H. Shen J, et al. Front Physiol. 2024 May 16;15:1337442. doi: 10.3389/fphys.2024.1337442. eCollection 2024. Front Physiol. 2024. PMID: 38818523 Free PMC article. Review.
Striatal DAT availability does not change after supraphysiological glucose loading dose in humans.
Pak K, Seo S, Lee MJ, Kim K, Suh S, Im HJ, Kim IJ. Pak K, et al. Endocr Connect. 2021 Oct 7;10(10):1266-1272. doi: 10.1530/EC-21-0355. Endocr Connect. 2021. PMID: 34491899 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information